Transplant Triumph

Transplant Triumph

The drugs used to keep patients from rejecting transplanted organs work by suppressing the immune system -- which in turn leaves the body open to infections and even cancer. But a recently developed technique targets only the new tissue. Creating a hybrid molecule out of a human protein and an antibody, scientists tricked mouse immune systems into accepting human pancreatic cells while rejecting other foreign tissue. If it works in people, transplants will become far safer.


Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!